Page 16 - Study Design News Today

Visiongain has published a new report entitled Decentralised Clinical Trials 2023-2033.   Forecasts by Indication (Oncology, Cardiovascular,...

Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in... | April 18, 2023

Contract Research Organization (CRO) Market Research Report: Information By Type (Drug Discovery, Clinical Development), By Clinical trial (Preclinical

Investegate announcements from atai Life Sciences, atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression

NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) ("atai" or "the Company"), a clinical-stage biopharmaceutical company focused on mental health, announced that,

Atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant DepressionNEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental h...

Patients’ race and ethnicity may play a role in mortality from Covid-19. Studies in China, the US, and Europe have been conducted on the predictors of Covid-19 mortality, yet in the EMR countries, such studies are scarce. Therefore, we aimed to describe the hospitalization rate, ICU-admission, and in-hospital mortality of Covid-19 and predictors of in-hospital mortality in Saudi Arabia. E-medical records were examined for all Covid-19 patients diagnosed in five tertiary hospitals affiliate...

High response rates and encouraging median progression free survival rates were observed in patients regardless of PIK3CA mutation statusMedian progression free survival (PFS) of 42.3 months was reported

BioArctic: Results from lecanemab confirmatory phase 3 Clarity AD study to be presented at 15th Clinical Trials on Alzheimer's Disease (CTAD) conference - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- The global clinical trials market valued USD 47.0 billion in 2021 and is anticipated to exhibit growth at a CAGR of 5.8% from 2022 to 2030. The...